The Marcus (MCS) Q4 2015 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2015 earnings summary
9 Nov, 2026Executive summary
FY2015 revenue reached a record $488.1M, up 9.0% YoY; operating income rose 3.7% to $50.2M.
Net earnings attributable to shareholders were $24.1M and diluted EPS was $0.87, down 4.0% and 5.4%; excluding unusual non-cash items in FY2014 and FY2015, earnings and EPS were up nearly 12%.
Financial highlights
FY2015 revenue was $488.1M vs. $447.9M in FY2014; operating income was $50.2M vs. $48.4M.
Net earnings were $24.0M vs. $25.0M; diluted EPS was $0.87 vs. $0.92.
Cash dividends per diluted share were $0.39 vs. $0.35, up 11.4%; shareholders’ equity increased 5.4% to $343.8M.
Outlook and guidance
FY2016 plans include expanding theatre features to more locations, beginning construction on two new theatres, and continuing loyalty, targeted marketing and sales initiatives.
Hotel growth is expected to focus on management contracts, with minority investments considered in some cases; additional theatre acquisitions remain an option if suitable opportunities arise.
Planned hotel investments include guest-room, lobby and restaurant renovations at the Skirvin Hilton, plus new bedding and guest amenities at select properties.
Latest events from The Marcus
- FY2023 rebounded across theatres and hotels, while film supply clouds the FY2024 theatre outlook.MCS
Q4 2023 - FY22 recovery lifted EBITDA, but film supply and business travel remain constraints.MCS
Q4 2022 - Recovery lifted FY2021 Adjusted EBITDA to $35.1M, but the net loss remained $43.3M.MCS
Q4 2021 - Pandemic closures drove a $124.8M loss, with recovery hinging on reopening and demand.MCS
Q4 2020 - Record revenue, lower earnings, and COVID-19 closures reshaped the outlook.MCS
Q4 2019 - Record revenue and operating income; Movie Tavern expands the footprint as FY2019 investment rises.MCS
Q4 2018 - Record earnings and theatre outperformance powered growth amid acquisition-led expansion.MCS
Q4 2016 - Record FY2017 results, boosted by theatre growth and a one-time tax benefit.MCS
Q4 2017 - F2014 earnings rose on stronger theatres and hotels, with elevated investment and market risks ahead.MCS
Q4 2014